| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; mouse; loading ...; fig e2c
| Harper K, Sosa M, Entenberg D, Hosseini H, Cheung J, Nobre R, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016;540:588-592 pubmed publisher |
- western blot; rat; 1:4000; fig 4
| Lyukmanova E, Shulepko M, Shenkarev Z, Bychkov M, Paramonov A, Chugunov A, et al. Secreted Isoform of Human Lynx1 (SLURP-2): Spatial Structure and Pharmacology of Interactions with Different Types of Acetylcholine Receptors. Sci Rep. 2016;6:30698 pubmed publisher |
- western blot; mouse; fig 5
| Ahmad F, Chung Y, Tang Y, Hockman S, Liu S, Khan Y, et al. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci Rep. 2016;6:28056 pubmed publisher |
- western blot; human; fig 3
| Ashford A, Dunkley T, Cockerill M, Rowlinson R, Baak L, Gallo R, et al. Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome. Cell Mol Life Sci. 2016;73:883-900 pubmed publisher |
| Cao M, Hou D, Liang H, Gong F, Wang Y, Yan X, et al. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1. Eur J Cancer. 2014;50:1013-24 pubmed publisher |
- western blot; mouse; 1:2000
| Evans C, Cook S, Coleman M, Gilley J. MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling. PLoS ONE. 2013;8:e76505 pubmed publisher |
| Zhao X, Sankaran S, Yap J, Too C, Ho Z, Dolton G, et al. Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling. Nat Commun. 2018;9:2716 pubmed publisher |
| Arvaniti M, Jensen M, Soni N, Wang H, Klein A, Thiriet N, et al. Functional interaction between Lypd6 and nicotinic acetylcholine receptors. J Neurochem. 2016;138:806-20 pubmed publisher |
| Lochhead P, Clark J, Wang L, Gilmour L, Squires M, Gilley R, et al. Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation. Cell Cycle. 2016;15:506-18 pubmed publisher |
| Wang N, Liang H, Zhou Y, Wang C, Zhang S, Pan Y, et al. miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. PLoS ONE. 2014;9:e105570 pubmed publisher |
| Kwon H, Jeong K, Hwang E, Park J, Pak Y. A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2. J Cell Mol Med. 2011;15:888-908 pubmed publisher |
| Kwon H, Jeong K, Pak Y. Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis. J Cell Mol Med. 2009;13:1549-64 pubmed publisher |
| Fletcher G, Xue L, Passingham S, Tolkovsky A. Death commitment point is advanced by axotomy in sympathetic neurons. J Cell Biol. 2000;150:741-54 pubmed |
